New guidelines for severe asthma provide an updated definition of the disease and a new plan to tack

December 11, 2013, European Lung Foundation

A new guideline has provided an updated definition of severe asthma along with new recommendations for treating the condition.

Produced by a joint task force of the European Respiratory Society and the American Thoracic Society, the guideline is published online today (12 December 2013) in the European Respiratory Journal.

Although severe is estimated to account for less than 10% of all asthmatics, these patients have the greatest burden and require a disproportionate amount of healthcare costs to be spent on treating their condition, which is harder to control.

The guideline defines severe asthma as "asthma which requires treatment with high dose inhaled corticosteroids (ICS) plus a second controller (long acting β2 agonist (LABA), leukotriene modifier, theophylline or systemic corticosteroids) to prevent it from becoming uncontrolled or which remains uncontrolled despite this therapy."

The definition is intended to help doctors to confirm a diagnosis of severe asthma and address associated factors that could be making asthma difficult to treat.

The guideline provides a detailed discussion of the classification (phenotyping) of patients with severe asthma as evidence suggests that severe asthma affects people in different ways.

Recent research has started to group severe asthma into different types (or phenotypes) based on clinical and certain biological features of the condition. These findings can help researchers develop targeted treatments for this group of people whose asthma remains difficult to treat despite taking the recommended therapies. The guideline encourages continuing research into phenotyping severe asthma and finding more effective treatments aimed particularly at specific phenotypes of severe asthma.

The document has produced recommendations using the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) method on the evaluation and treatment of severe asthma. Recommendations were made on five treatments that have been used or proposed for use in severe asthma namely anti-IgE treatment, methotrexate, anti-fungal treatment, macrolide antibiotics and bronchial thermoplasty.

Co-lead author, Professor Fan Chung, from Imperial College London and the Royal Brompton Hospital, said: "This new guideline provides a platform to help us understand severe asthma and how to treat it. As the evidence available for the field of severe asthma is only just emerging, we must take the opportunity to build on this knowledge and increase our efforts to ultimately provide personalised medicine to people with this condition."

Guy Brusselle, Guidelines Director for the European Respiratory Society, said: "Although severe asthma cases are a relatively smaller proportion of all asthma cases, people with this condition can experience breathlessness all the time, as well as frequent and attacks, requiring hospitalisation. This seriously impairs quality of life for an individual and represents a huge financial burden for society. These new guidelines provide recommendations for an approach to diagnose and treat the condition and it's our responsibility to now ensure they are implemented for the benefit of patients."

Explore further: Severe asthma patients less responsive to treatment

More information: International ERS/ATS Guidelines on Definition, Evaluation and Treatment of Severe Asthma, Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock IM, Bateman ED, Bel EH, Bleecker ER, Boulet L-P, Brightling C, Chanez P, Dahlen S-E, Djukanovic R, Frey U, Gaga M, Gibson P, Hamid Q, Jajour NN, Mauad T, Sorkness RL, Teague WG, DOI: 10.1183/09031936.00202013

Editorial: Trustworthy guidelines on severe asthma thanks to ERS and ATS, Brusselle GG, Kraft M, DOI: 10.1183/09031936.00191113

Related Stories

Severe asthma patients less responsive to treatment

September 9, 2013
People with severe asthma, who are often described as 'steroid-dependent', are actually less likely to respond to the treatment they depend on, when compared to people with mild asthma.

Bronchial thermoplasty shows long-term effectiveness for asthma

December 2, 2013
The beneficial effects of bronchial thermoplasty, a non-pharmacologic treatment for asthma, last at least five years, according to researchers at National Jewish Health and other institutions. The therapy, in which heat is ...

Hope of new treatment for severe asthma patients

October 25, 2013
New research from Japan brings hope of a new treatment for asthma patients resistant to corticosteroids. In a study published today in the journal Nature Communications, researchers from the RIKEN Center for Integrative Medical ...

Good asthma control during pregnancy is vital says new review

September 6, 2013
Good asthma management during pregnancy is vital during pregnancy as poor asthma control can have adverse effects on maternal and fetal outcomes, says a new review published today in The Obstetrician & Gynaecologist (TOG).

Obese youth more likely to develop asthma

August 9, 2013
(HealthDay)—Obese youth are more likely to develop asthma, and are more likely to have severe asthma, according to a study published online Aug. 6 in the American Journal of Epidemiology.

Discovery of asthma cause could help treat sufferers

October 5, 2011
(Medical Xpress) -- Scientists at the University of Bath have found a new cause of severe asthma that could help develop a treatment and potentially prevent the 1100 asthma deaths each year in the UK.

Recommended for you

Chronic inflammation causes loss of muscle mass during aging

January 12, 2018
People start losing muscle mass at the age of 40—about some 10 percent of the total muscle mass for each 10-year period, which may lead to fall-related injuries, slowing metabolism and reduced quality of life. Today, very ...

Breathing exercises help asthma patients with quality of life

December 13, 2017
A study led by the University of Southampton has found that people who continue to get problems from their asthma, despite receiving standard treatment, experience an improved quality of life when they are taught breathing ...

Study highlights the need for research into prevention of inflammatory bowel disease

December 7, 2017
Countries in Africa, Asia, the Middle East and South America have seen a rise in incidence of inflammatory bowel disease as they have become increasingly industrialised and westernised, a new study has found.

Air pollution can increase asthma risk in adults, even at low levels

November 24, 2017
Living close to a busy road can be bad for your respiratory health if you are middle aged, new Australian research has found.

Evidence found of oral bacteria contributing to bowel disorders

October 20, 2017
(Medical Xpress)—An international team of researchers has found evidence that suggests certain types of oral bacteria may cause or exacerbate bowel disorders. In their paper published in the journal Science, the group describes ...

New compound discovered in fight against inflammatory disease

September 22, 2017
A 10-year study by University of Manchester scientists for a new chemical compound that is able to block a key component in inflammatory illness has ended in success.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.